Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Police say violent crime improving in downtown Raleigh, but more work is needed
Recommended
Back to school guide: Buses, lunches, key dates
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Filament Health Corp
(OP:
FLHLF
)
0.0465
UNCHANGED
Streaming Delayed Price
Updated: 3:26 PM EDT, Aug 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Filament Health Corp
< Previous
1
2
3
Next >
Optimi Health Signs Two New Supply Agreements In Less Than a Week
May 31, 2022
Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies.
Via
Benzinga
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say
May 20, 2022
Patents are the golden eggs of the booming psychedelic space.
Via
Benzinga
Filament Health Keeps Adding Patents To Its Portfolio, Just Received Its Fourth
April 27, 2022
Just two weeks ago, Filament Health (OTCQB: FLHLF) was issued a patent by the U. S. Patent and Trademark Office to extract and standardize natural psilocybin.
Via
Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
Filament Health Talks Psilocybins, Psilocins And How Natural Psychedelics Could Conquer The Market
April 22, 2022
Filament Health (OTCQB: FLHLF) (NEO:FH) is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines.
Via
Benzinga
Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know
April 19, 2022
Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the...
Via
Benzinga
Filament Health Acquires Patent For Extracting And Standardizing Natural Psilocybin
April 13, 2022
Filament Health Corp. (OTCQB: FLHLF) announced that the U. S. Patent and Trademark Office (USPTO) issued a patent that will allow the company to extract and standardize natural psilocybin and...
Via
Benzinga
Filament Health Corp. (FLHLF) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 11, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins
February 07, 2022
This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE.
Via
Benzinga
Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants
January 31, 2022
Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants.
Via
Benzinga
Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington
January 10, 2022
Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov...
Via
Benzinga
How One Company Says It Aims To Demonstrate the Superiority of Psilocin Over Psilocybin in Treating Mental Health Conditions
November 16, 2021
Image by Mathew Schwartz from Unsplash The following post was written and/or pu...
Via
Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Detroit Decriminalizes Psychedelics
Via
Benzinga
Exposures
Product Safety
The Power Play by The Market Herald Releases New Interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven Brands Inc., and Xali Gold Corp.
November 03, 2021
VANCOUVER, BC / ACCESSWIRE / November 3, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven...
From
The Market Herald
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Product Safety
Psychedelic Stock Filament Health Jumps On Announcing First Psilocin Clinical Trial
November 02, 2021
Psychedelic drug discovery company Filament Health Corp. (OTCQB:
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.